Torrent Pharmaceuticals Limited
Torrent Pharma filed a disclosure regarding post-listing non-convertible debentures (NCDs) in compliance with SEBI regulations. The filing provides comprehensive details of NCDs issued and outstanding as of March 31, 2026, and confirms no default history in debt servicing.
Apr 23 2026 19:04:00
Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals disclosed details of listed debt securities issued through private placement for the half year ended March 31, 2026. The disclosure includes approximately ₹10,990 crore in outstanding NCDs across four issuances with coupon rates up to 7.80%, and confirmed the redemption of NCDs (ISIN INE685A07082) on December 12, 2025.
Apr 15 2026 11:04:00
Torrent Pharmaceuticals Limited
Torrent Pharma's Bileshwarpura (Oncology) facility underwent a USFDA inspection from April 6-10, 2026. The inspection concluded with zero observations, indicating compliance with regulatory standards.
Apr 10 2026 19:04:00
Torrent Pharmaceuticals Ltd - 500420 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Torrent Pharma's Bileshwarpura (Oncology) facility underwent a USFDA inspection from 06-Apr-26 to 10-Apr-26. The inspection concluded successfully with zero observations, indicating high compliance standards.
Apr 10 2026 19:04:00
Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals confirmed the full utilization of Commercial Papers proceeds by March 31, 2026. This utilization was in line with the purpose disclosed in the Disclosure Document and adhered to SEBI regulations.
Apr 06 2026 17:04:00
Torrent Pharmaceuticals Ltd - 500420 - Sale Of Equity Shares Of UNM Foundation (Section 8 Company), Associate Company
Torrent Pharmaceuticals sold 50,000 equity shares of UNM Foundation for ₹5,00,000 to its holding company and promoter, Torrent Investments Limited. This related-party transaction involves the disposal of shares in an associate company.
Mar 30 2026 20:03:00
Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals sold 50,000 equity shares of UNM Foundation, an associate company, to its holding company, Torrent Investments Limited. The transaction was valued at ₹5,00,000 and was completed on March 30, 2026, as a related party transaction.
Mar 30 2026 20:03:00
Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Torrent Pharmaceuticals will convene an equity shareholders' meeting on April 28, 2026. This meeting, directed by the NCLT, is for considering and approving the scheme of amalgamation with J. B. Chemicals & Pharmaceuticals Limited.
Mar 28 2026 17:03:00
Torrent Pharmaceuticals Limited
Torrent Pharma will hold an NCLT convened meeting for equity shareholders on April 28, 2026, to consider the Scheme of Amalgamation with J. B. Chemicals & Pharmaceuticals Limited. Remote e-voting will be available from April 24 to April 27, 2026.
Mar 28 2026 17:03:00
Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals to hold a Court Convened Meeting on April 28, 2026. Shareholders will vote on the special resolution for the amalgamation with J.B. Chemicals & Pharmaceuticals Limited under Sections 230 to 232 of the Companies Act, 2013.
Mar 28 2026 16:03:00
Read More